1. Institute of Molecular and Clinical Immunology, Otto-von-Guericke University, Magdeburg, Germany;
2. Institute of Immunology, Hannover Medical School, Hannover, Germany;
3. Department of Vascular Biology, Max-Planck-Institute for Molecular Biomedicine, Münster, Germany;
4. Protein Engineering Group, Leibniz Institute of Molecular Pharmacology, Freie Universität Berlin, Berlin, Germany,
5. Molecular Medicine, Max-Planck-Institute for Biochemistry, Martinsried, Germany; and
6. Department of Immune Control, Helmholtz Centre for Infection Research, Braunschweig, Germany